Vaccines - Research and Data from KFF

COVID-19 Vaccines Could Cost Billions of Dollars More Each Year If the Federal Government Ends Its Bulk Purchasing Program

Dec 7, 2022

News Release

If the federal government runs out of money to purchase COVID-19 vaccines, the per-dose price likely would skyrocket and could increase spending on vaccines by billions of dollars a year, a new KFF analysis finds. To date, the federal government has spent more than $30 billion on COVID-19 vaccines to encourage their development, guarantee a market, and ensure that the public can access them at no charge. The Biden administration has said it can no…

Why Do Vaccinated People Represent Most COVID-19 Deaths Right Now?

Nov 30, 2022

Policy Watch

This post explores why the share of COVID-19 deaths among those who are vaccinated has risen, Factors include a rising share of the population that is vaccinated, waning immune protection and low uptake of boosters, and changes in immunity among the unvaccinated.

The COVAX Humanitarian Buffer for COVID-19 Vaccines: Review and Assessment of Policy Implications

Nov 30, 2022

Issue Brief

In this Issue Brief we review and assess the COVAX Humanitarian Buffer mechanism, which is part of the effort to share Covid vaccines globally. The Buffer is intended to direct vaccines to vulnerable people like refugees and others facing humanitarian emergencies during the pandemic, and was supported by the US and many other donors and organizations. However, it faced many challenges such as liability and indemnification issues for using newly developed vaccines, restricted access to…

Update on Children’s COVID-19 and Routine Vaccination Trends Heading into Winter and as Respiratory Viruses Surge

Nov 9, 2022

Policy Watch

This policy watch describes recent trends in children’s COVID-19 and routine vaccinations and explores strategies to increase vaccination rates among children as we head into the winter season.

Deaths Among Older Adults Due to COVID-19 Jumped During the Summer of 2022 Before Falling Somewhat in September

Oct 6, 2022

Issue Brief

This analysis uses CDC data to look at deaths from COVID-19 for adults 65 and older. The findings show that deaths for older adults doubled from April to July 2022 and stayed high in August, before dropping again in September.

National Data Show Continuing Disparities in Monkeypox (MPX) Cases and Vaccinations Among Black and Hispanic People

Oct 5, 2022

Issue Brief

This analysis examines monkeypox (MPX) cases and vaccinations by race/ethnicity based on national data obtained from the Centers for Disease Control and Prevention (CDC). We find that while the current MPX outbreak in U.S. appears to be slowing down, disparities persist among Black and Hispanic people.

The U.S. Government and Global Polio Efforts

Oct 3, 2022

Fact Sheet

This fact sheet provides a snapshot of global polio eradication efforts and examines the U.S. government’s role in addressing polio worldwide.

KFF COVID-19 Vaccine Monitor: September 2022

Sep 30, 2022

Poll Finding

Our latest Vaccine Monitor survey finds that half of the public has heard either “a lot” or “some” about the newly-available bivalent COVID-19 boosters, and a third (32%) say they’ve already gotten it or intend to do so “as soon as possible.” It also updates parents’ vaccine intentions for their children, including those under 5.

Half of Public Has Heard Little or Nothing About the New COVID-19 Booster Aimed at Omicron; Many Don’t Know If the CDC Recommends That They Get the New Booster

Sep 30, 2022

News Release

Nearly 1 in 5 Parents of Children Under 5 Say Their Child Has Gotten a Vaccine, up from 7% in July, Though Half Say They Will “Definitely Not” Get Their Child Vaccinated Less than a month after the Food and Drug Administration authorized new COVID-19 booster shots that target both the omicron and original strains, public awareness is modest, a new KFF COVID-19 Vaccine Monitor survey finds. Half the public says they’ve heard either “a…

Medicaid and the Inflation Reduction Act of 2022

Sep 22, 2022

Policy Watch

The recent passage of the Inflation Reduction Act of 2022 (IRA) includes a number of climate, tax, and health care provisions and prescription drug reforms. This policy watch explores the potential impacts of the Inflation Reduction Act on overall Medicaid spending as well as implications for Medicaid beneficiaries.

Topics

Policy Research

Polling

Health News

Data & Features

For Media

About

View the Latest: Vaccines

Filter